Inspira Tech Develops New Disposable Kit with Monitoring
Ticker: IINNW · Form: 6-K · Filed: Oct 9, 2024 · CIK: 1837493
Sentiment: neutral
Topics: product-development, medical-devices, press-release
TL;DR
Inspira Tech unveils new disposable kit with built-in monitoring – potential game-changer for medical devices.
AI Summary
On October 9, 2024, Inspira Technologies Oxy B.H.N. Ltd. announced the development of a new disposable kit featuring a built-in performance monitoring mechanism. This innovation aims to enhance the functionality and safety of their medical devices. The press release detailing this development is filed as Exhibit 99.1 with their Form 6-K.
Why It Matters
This development could lead to improved patient safety and more efficient medical procedures by providing real-time performance data from the disposable kit.
Risk Assessment
Risk Level: medium — The filing is a routine report of a new product development, but the actual market impact and success of this new kit are yet to be determined.
Key Players & Entities
- Inspira Technologies Oxy B.H.N. Ltd. (company) — Registrant
- October 9, 2024 (date) — Date of press release
- Exhibit 99.1 (document) — Filed document
FAQ
What is the primary innovation of the new disposable kit announced by Inspira Technologies?
The new disposable kit features a built-in performance monitoring mechanism.
When was the press release announcing this development issued?
The press release was issued on October 9, 2024.
What is the filing form associated with this announcement?
The announcement is part of a Form 6-K filing.
Where is Inspira Technologies Oxy B.H.N. Ltd. based?
The company's principal executive office is located in Ra'anana, Israel.
What type of report does Inspira Technologies file annually, according to the filing?
Inspira Technologies files annual reports under cover of Form 20-F.
Filing Stats: 301 words · 1 min read · ~1 pages · Grade level 9.4 · Accepted 2024-10-09 16:01:13
Filing Documents
- ea0217153-6k_inspira.htm (6-K) — 11KB
- ea021715301ex99-1_inspira.htm (EX-99.1) — 11KB
- 0001213900-24-086610.txt ( ) — 23KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Inspira Technologies Oxy B.H.N. Ltd. Date: October 9, 2024 By: /s/ Dagi Ben-Noon Name: Dagi Ben-Noon Title: Chief Executive Officer 2